At present cancer patients can only receive drugs registered for the type of cancer that they are battling. Sometimes the drugs have no impact and a different drug registered for a different type of cancer could help.
The Belgian Society of Medical Oncology is now taking an initiative bringing seven university hospitals together with pharmaceutical companies. As a result Belgium will be one of the first countries where patients can use drugs registered for a different type of cancer than the one they are suffering from.
Jacques De Grève of the Belgian Society of Medical Oncology: "Not the type of cancer but the type of mutation in cancer cells will determine which drug you get. In this way patients will receive access to a broader range of drugs that can be beneficial for them. This can save lives and lengthen life span or improve life quality."